Form 4 for CYRX Cryoport, Inc.
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-14 · accession 0001104659-25-025194 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-18 | 2025-03-14 | CYRX | STEFANOVICH ROBERT | CFO | A - Grant | $0.00 | +10.0K | 193.1K | +5% | $0 |
| D | 2025-03-18 | 2025-03-17 | CYRX | STEFANOVICH ROBERT | CFO | S - Sale | $6.29 | -1,659 | 191.4K | -0.9% | -$10.4K |
| D | 2025-03-18 | 2025-03-14 | CYRX | STEFANOVICH ROBERT | CFO | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-14 | A | A | 10,000 | $0.00 | 193,078 | D | — | — | (F1) Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026. |
| 2 | Common | Common Stock | 2025-03-17 | S | D | 1,659 | $6.29 | 191,419 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-03-14 | A | A | 25,000 | $0.00 | 25,000 | D | $7.05 · — to 2032-03-14 | 25,000 Common Stock | (F3) 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025. |